“The DEA is looking to expand its anti-diversion surveillance infrastructure by being able to search and analyze myriad patient behaviors for the vast majority of controlled and scheduled drug prescriptions—all accompanied by a rapid process for legally unveiling personally identifying information.”
“In early September, the agency requested proposals for the creation of software capable of searching at least 85 percent of all US residents’ controlled-substance prescriptions for certain patient behaviors, as well as prescriber and pharmacist practices.”
The DEA wants to give their agents “unlimited access to patient de-identified data” on re/filled prescriptions, daily supply, payment type, dosing information and gender.”
The “de-identified” data the DEA will have access to includes things like a patients, gender, age group, city, state, zip code and the number of instances of more than one Schedule II prescription drug at the same address. It also includes things like the distance between a patient and the pharmacy.
The DEA’s Prescription Monitoring Program would let at least 1,100 DEA agents have access to the so-called de-identified patient prescription data simultaneously and it would also have a streamlined subpoena process. (pages 11 and 13 of the DEA’s Proposal for Pharmacy Prescription Data in Filter Mag. )
Why would the DEA want to give 1,100 agents access to “de-identified” patient prescription data and why would they want a streamlined subpoena process if they could not identify individuals?
According to a 2016 NPR article the DEA could be monitoring 119 million Americans taking prescription drugs.
“Nearly half of all Americans over the age of 12 take prescription pain relievers, tranquilizers, sedatives or stimulants, according to a federal survey. And 16 percent of the time those drugs are misused by nearly 19 million Americans. Health officials are calling for more drug treatment, but also for more care in prescribing drugs in the first place.”
The national survey on drug use revealed that at least 119 million Americans took painkillers, tranquilizers, stimulants and sedatives.
The DEA wants access to 131 million Americans prescription information
A more recent study by Georgetown University’s, Health Policy Institute claims that at least 66 percent of the population or 131 million Americans are on prescription drugs.
“More than 131 million people — 66 percent of all adults in the United States — use prescription drugs. The great majority of adults who have one of five common chronic conditions — diabetes, heart disease, hypertension, arthritis, and cancer — use prescription drugs.”
Whichever figure is correct 119 million or 131 million, the obvious question everyone should be asking is, why does the DEA need access to millions of elderly Americans’ prescription information?
“The proportion of people using prescription drugs and the amount of prescriptions filled varies by demographic group. Prescription drug use is associated with age, gender, race and ethnicity, income, and health status. For example, prescription drug use increases with age. Three-quarters of those age 50 to 64 use prescription drugs, compared to 91 percent of those age 80 and older. The average number of prescriptions filled also increases with age, from 13 for those age 50 to 64 to 22 for those age 80 and older.”
Who in their right mind believes that millions of elderly Americans taking prescription drugs should be treated like suspected criminals? Yet that is exactly what is happening. When the Feds are allowed to create and use a surveillance program masquerading as a prescription monitoring program, no one is safe, not kids, teenagers or the elderly.
Welcome to post 9/11 where the Feds treat everyone taking prescription drugs like a suspect.
As Filter Mag warns, the DEA has a history of exploiting administrative subpoenas to build a mass surveillance apparatus. The DEA’s 343 million license plate database is a perfect example of how the DEA has secretly created a national license plate surveillance network.
Allowing the DEA to scrutinize the percentage of patients receiving Opioids, Buprenorphine or Oxycodone scripts is horrifying. If you have ever had to fill a prescription or pick up one for a family member you know that they record your ID and all your personal information.
“The impact of including buprenorphine will be appalling for people’s health,” Dr. Hannah Cooper, the chair of substance use disorder research at Emory University said.
“The idea that patient-level data is available to the DEA is quite frightening. We don’t want to make people worry that their decisions will be monitored by this highly punitive federal agency,” said Cooper. “If you’ve been inhabiting a space where you’ve been persecuted by the federal government for some time, and they now have access to your private medical information, there will be tremendous consequences for population health and health equity.”
Here’s one example of how law enforcement could abuse monitoring 131 million prescription records.
Imagine being involved in an automobile accident or being arrested for protesting police abuse, etc. Now imagine what would happen when the District Attorney subpoena’s your prescription drug history. Can you guess what the outcome would be once a judge and or jury is told about your prescription drug history.
This is just one example of how everyone’s lives could be affected by a Federal prescription monitoring program.